Skip to main content
All lobbying filings

CAPITOL HILL CONSULTING GROUP

Lobbying for CHARLES RIVER LABORATORIES INTERNATIONAL, INC · Contract Research Organization

 Filing Registration
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Feb 6, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Massachusetts

Official filing document

 Lobbyists on this filing 4
  • KIMBERLEE TRZECIAK New on this filing
    Previously held: FDA. Dep. Commissioner; 8/23-1/25. Assoc. Commissioner Leg. Affairs; 2/2022-08/2023. House Com. Energy & Commerce: Chief Health Advisor, 2/22-4/19. Sen. Health Policy Advisor, 3/19-3/15. Rep. John D. Dingell - LD, 05/13-07/11. Sen. LA, 7/11-08/09, LA
  • EMILY ELIZABETH WILKINSON-HOLLAND New on this filing
    Previously held: Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19).
  • CHRISTOPHER DAVIS New on this filing
    Previously held: Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011).
  • BRIAN SUTTER New on this filing
    Previously held: Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Lobbying activity 3
Health Issues

Issues surrounding improvements to clinical research capabilities and modernization of research methods.

Food Industry (safety, labeling, etc.)

Issues surrounding improvements to clinical research capabilities and modernization of research methods.

Pharmacy

Issues surrounding improvements to clinical research capabilities and modernization of research methods.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem